nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Disulfiram—alcohol dependence	0.21	0.378	CbGbCtD
Dolasetron—CYP2D6—Citalopram—alcohol dependence	0.137	0.246	CbGbCtD
Dolasetron—CYP3A4—Disulfiram—alcohol dependence	0.122	0.22	CbGbCtD
Dolasetron—CYP3A4—Citalopram—alcohol dependence	0.087	0.157	CbGbCtD
Dolasetron—HTR3A—Ligand-gated ion channel transport—GABRB1—alcohol dependence	0.00908	0.0768	CbGpPWpGaD
Dolasetron—HTR3A—Ligand-gated ion channel transport—GABRA2—alcohol dependence	0.00772	0.0653	CbGpPWpGaD
Dolasetron—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00477	0.0403	CbGpPWpGaD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00467	0.0395	CbGpPWpGaD
Dolasetron—Hyoscyamine—CHRM2—alcohol dependence	0.00449	0.54	CrCbGaD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00387	0.0327	CbGpPWpGaD
Dolasetron—Atropine—CHRM2—alcohol dependence	0.00382	0.46	CrCbGaD
Dolasetron—HTR3A—nerve—alcohol dependence	0.00356	0.188	CbGeAlD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00329	0.0278	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00305	0.0258	CbGpPWpGaD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.0028	0.0237	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00253	0.0214	CbGpPWpGaD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00245	0.0208	CbGpPWpGaD
Dolasetron—Urine output increased—Acamprosate—alcohol dependence	0.00221	0.0074	CcSEcCtD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00215	0.0182	CbGpPWpGaD
Dolasetron—Abnormal vision—Acamprosate—alcohol dependence	0.00213	0.00714	CcSEcCtD
Dolasetron—Depersonalisation—Citalopram—alcohol dependence	0.00209	0.007	CcSEcCtD
Dolasetron—Phlebitis—Acamprosate—alcohol dependence	0.00206	0.0069	CcSEcCtD
Dolasetron—Influenza-like symptoms—Citalopram—alcohol dependence	0.00205	0.00687	CcSEcCtD
Dolasetron—Thrombophlebitis—Acamprosate—alcohol dependence	0.00205	0.00687	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.00204	0.00683	CcSEcCtD
Dolasetron—Polyuria—Acamprosate—alcohol dependence	0.00202	0.00677	CcSEcCtD
Dolasetron—Ventricular arrhythmia—Citalopram—alcohol dependence	0.00198	0.00663	CcSEcCtD
Dolasetron—HTR3A—Ion channel transport—GABRB1—alcohol dependence	0.00197	0.0167	CbGpPWpGaD
Dolasetron—Phlebitis—Naltrexone—alcohol dependence	0.00195	0.00653	CcSEcCtD
Dolasetron—Sleep disorder—Naltrexone—alcohol dependence	0.00194	0.0065	CcSEcCtD
Dolasetron—Renal failure acute—Acamprosate—alcohol dependence	0.00192	0.00644	CcSEcCtD
Dolasetron—Increased appetite—Acamprosate—alcohol dependence	0.00189	0.00633	CcSEcCtD
Dolasetron—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00186	0.0158	CbGpPWpGaD
Dolasetron—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00185	0.0156	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00183	0.0155	CbGpPWpGaD
Dolasetron—Myocardial ischaemia—Citalopram—alcohol dependence	0.00182	0.00611	CcSEcCtD
Dolasetron—Increased appetite—Naltrexone—alcohol dependence	0.00179	0.00599	CcSEcCtD
Dolasetron—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00178	0.00597	CcSEcCtD
Dolasetron—Purpura—Naltrexone—alcohol dependence	0.00174	0.00583	CcSEcCtD
Dolasetron—Extrasystoles—Citalopram—alcohol dependence	0.00174	0.00583	CcSEcCtD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00173	0.0146	CbGpPWpGaD
Dolasetron—Face oedema—Acamprosate—alcohol dependence	0.00171	0.00574	CcSEcCtD
Dolasetron—HTR3A—Ion channel transport—GABRA2—alcohol dependence	0.00168	0.0142	CbGpPWpGaD
Dolasetron—Face oedema—Naltrexone—alcohol dependence	0.00162	0.00543	CcSEcCtD
Dolasetron—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00162	0.00543	CcSEcCtD
Dolasetron—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00161	0.0054	CcSEcCtD
Dolasetron—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00161	0.0136	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.0016	0.0136	CbGpPWpGaD
Dolasetron—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0016	0.00535	CcSEcCtD
Dolasetron—Oliguria—Citalopram—alcohol dependence	0.00159	0.00533	CcSEcCtD
Dolasetron—Paraesthesia—Disulfiram—alcohol dependence	0.00159	0.00533	CcSEcCtD
Dolasetron—Somnolence—Disulfiram—alcohol dependence	0.00157	0.00527	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00156	0.00524	CcSEcCtD
Dolasetron—Dehydration—Naltrexone—alcohol dependence	0.00156	0.00523	CcSEcCtD
Dolasetron—Abdominal distension—Acamprosate—alcohol dependence	0.00154	0.00517	CcSEcCtD
Dolasetron—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00153	0.0129	CbGpPWpGaD
Dolasetron—HTR3A—brainstem—alcohol dependence	0.00153	0.0807	CbGeAlD
Dolasetron—Fatigue—Disulfiram—alcohol dependence	0.00153	0.00511	CcSEcCtD
Dolasetron—Pain—Disulfiram—alcohol dependence	0.00151	0.00507	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00151	0.00506	CcSEcCtD
Dolasetron—Pancreatitis—Acamprosate—alcohol dependence	0.0015	0.00504	CcSEcCtD
Dolasetron—Muscle twitching—Citalopram—alcohol dependence	0.00149	0.005	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00148	0.00496	CcSEcCtD
Dolasetron—HTR3A—forebrain—alcohol dependence	0.00147	0.0779	CbGeAlD
Dolasetron—Ventricular tachycardia—Citalopram—alcohol dependence	0.00146	0.00491	CcSEcCtD
Dolasetron—Hiccups—Citalopram—alcohol dependence	0.00146	0.00491	CcSEcCtD
Dolasetron—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00146	0.00491	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00145	0.0122	CbGpPWpGaD
Dolasetron—Eructation—Citalopram—alcohol dependence	0.00144	0.00482	CcSEcCtD
Dolasetron—Influenza like illness—Citalopram—alcohol dependence	0.00142	0.00477	CcSEcCtD
Dolasetron—Sweating increased—Naltrexone—alcohol dependence	0.00141	0.00473	CcSEcCtD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00138	0.0117	CbGpPWpGaD
Dolasetron—Photophobia—Citalopram—alcohol dependence	0.00138	0.00461	CcSEcCtD
Dolasetron—Aplastic anaemia—Citalopram—alcohol dependence	0.00138	0.00461	CcSEcCtD
Dolasetron—Pneumonia—Acamprosate—alcohol dependence	0.00137	0.00461	CcSEcCtD
Dolasetron—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00135	0.00452	CcSEcCtD
Dolasetron—Myocardial infarction—Acamprosate—alcohol dependence	0.00134	0.00449	CcSEcCtD
Dolasetron—Stomatitis—Acamprosate—alcohol dependence	0.00133	0.00446	CcSEcCtD
Dolasetron—Urine output increased—Citalopram—alcohol dependence	0.00132	0.00444	CcSEcCtD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00131	0.0111	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0013	0.011	CbGpPWpGaD
Dolasetron—Haematuria—Acamprosate—alcohol dependence	0.0013	0.00437	CcSEcCtD
Dolasetron—Pneumonia—Naltrexone—alcohol dependence	0.0013	0.00436	CcSEcCtD
Dolasetron—Epistaxis—Acamprosate—alcohol dependence	0.00129	0.00432	CcSEcCtD
Dolasetron—Abnormal vision—Citalopram—alcohol dependence	0.00128	0.00428	CcSEcCtD
Dolasetron—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00127	0.00427	CcSEcCtD
Dolasetron—Sepsis—Citalopram—alcohol dependence	0.00127	0.00426	CcSEcCtD
Dolasetron—Asthenia—Disulfiram—alcohol dependence	0.00127	0.00426	CcSEcCtD
Dolasetron—Myocardial infarction—Naltrexone—alcohol dependence	0.00127	0.00425	CcSEcCtD
Dolasetron—Phlebitis—Citalopram—alcohol dependence	0.00123	0.00414	CcSEcCtD
Dolasetron—Sleep disorder—Citalopram—alcohol dependence	0.00123	0.00412	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00122	0.0041	CcSEcCtD
Dolasetron—Epistaxis—Naltrexone—alcohol dependence	0.00122	0.00409	CcSEcCtD
Dolasetron—Polyuria—Citalopram—alcohol dependence	0.00121	0.00406	CcSEcCtD
Dolasetron—Oedema peripheral—Acamprosate—alcohol dependence	0.00121	0.00405	CcSEcCtD
Dolasetron—Vascular purpura—Citalopram—alcohol dependence	0.00119	0.00398	CcSEcCtD
Dolasetron—Visual impairment—Acamprosate—alcohol dependence	0.00118	0.00396	CcSEcCtD
Dolasetron—Dizziness—Disulfiram—alcohol dependence	0.00117	0.00392	CcSEcCtD
Dolasetron—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.00116	0.00978	CbGpPWpGaD
Dolasetron—Renal failure acute—Citalopram—alcohol dependence	0.00115	0.00386	CcSEcCtD
Dolasetron—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00115	0.00969	CbGpPWpGaD
Dolasetron—Tinnitus—Acamprosate—alcohol dependence	0.00114	0.00383	CcSEcCtD
Dolasetron—Increased appetite—Citalopram—alcohol dependence	0.00113	0.00379	CcSEcCtD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00113	0.00956	CbGpPWpGaD
Dolasetron—Rash—Disulfiram—alcohol dependence	0.00112	0.00374	CcSEcCtD
Dolasetron—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00111	0.0094	CbGpPWpGaD
Dolasetron—Headache—Disulfiram—alcohol dependence	0.00111	0.00372	CcSEcCtD
Dolasetron—Purpura—Citalopram—alcohol dependence	0.0011	0.0037	CcSEcCtD
Dolasetron—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.0011	0.00932	CbGpPWpGaD
Dolasetron—Chills—Acamprosate—alcohol dependence	0.0011	0.00369	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.0011	0.00928	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00109	0.00922	CbGpPWpGaD
Dolasetron—Tinnitus—Naltrexone—alcohol dependence	0.00108	0.00363	CcSEcCtD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00108	0.00914	CbGpPWpGaD
Dolasetron—Flatulence—Acamprosate—alcohol dependence	0.00105	0.00353	CcSEcCtD
Dolasetron—Dysgeusia—Acamprosate—alcohol dependence	0.00105	0.00351	CcSEcCtD
Dolasetron—Chills—Naltrexone—alcohol dependence	0.00104	0.00349	CcSEcCtD
Dolasetron—HTR3A—digestive system—alcohol dependence	0.00103	0.0547	CbGeAlD
Dolasetron—Face oedema—Citalopram—alcohol dependence	0.00103	0.00344	CcSEcCtD
Dolasetron—Cardiac arrest—Citalopram—alcohol dependence	0.00101	0.00339	CcSEcCtD
Dolasetron—Urinary retention—Citalopram—alcohol dependence	0.00101	0.00339	CcSEcCtD
Dolasetron—Tremor—Acamprosate—alcohol dependence	0.001	0.00335	CcSEcCtD
Dolasetron—Ataxia—Citalopram—alcohol dependence	0.001	0.00335	CcSEcCtD
Dolasetron—Flatulence—Naltrexone—alcohol dependence	0.000996	0.00334	CcSEcCtD
Dolasetron—Ill-defined disorder—Acamprosate—alcohol dependence	0.000991	0.00332	CcSEcCtD
Dolasetron—Dysgeusia—Naltrexone—alcohol dependence	0.00099	0.00332	CcSEcCtD
Dolasetron—Dehydration—Citalopram—alcohol dependence	0.000989	0.00331	CcSEcCtD
Dolasetron—Anaemia—Acamprosate—alcohol dependence	0.000987	0.00331	CcSEcCtD
Dolasetron—HTR3A—blood—alcohol dependence	0.000985	0.0521	CbGeAlD
Dolasetron—Agitation—Acamprosate—alcohol dependence	0.000982	0.00329	CcSEcCtD
Dolasetron—Angioedema—Acamprosate—alcohol dependence	0.000976	0.00327	CcSEcCtD
Dolasetron—Orthostatic hypotension—Citalopram—alcohol dependence	0.000971	0.00325	CcSEcCtD
Dolasetron—Malaise—Acamprosate—alcohol dependence	0.000963	0.00323	CcSEcCtD
Dolasetron—Vertigo—Acamprosate—alcohol dependence	0.00096	0.00322	CcSEcCtD
Dolasetron—Syncope—Acamprosate—alcohol dependence	0.000958	0.00321	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000958	0.00321	CcSEcCtD
Dolasetron—Tremor—Naltrexone—alcohol dependence	0.000947	0.00317	CcSEcCtD
Dolasetron—Palpitations—Acamprosate—alcohol dependence	0.000944	0.00316	CcSEcCtD
Dolasetron—Loss of consciousness—Acamprosate—alcohol dependence	0.000939	0.00315	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000938	0.00314	CcSEcCtD
Dolasetron—Ill-defined disorder—Naltrexone—alcohol dependence	0.000938	0.00314	CcSEcCtD
Dolasetron—Cough—Acamprosate—alcohol dependence	0.000932	0.00312	CcSEcCtD
Dolasetron—Agitation—Naltrexone—alcohol dependence	0.000929	0.00311	CcSEcCtD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000926	0.00784	CbGpPWpGaD
Dolasetron—Convulsion—Acamprosate—alcohol dependence	0.000926	0.0031	CcSEcCtD
Dolasetron—Abdominal distension—Citalopram—alcohol dependence	0.000925	0.0031	CcSEcCtD
Dolasetron—Angioedema—Naltrexone—alcohol dependence	0.000923	0.00309	CcSEcCtD
Dolasetron—Hypertension—Acamprosate—alcohol dependence	0.000922	0.00309	CcSEcCtD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000918	0.00777	CbGpPWpGaD
Dolasetron—Malaise—Naltrexone—alcohol dependence	0.000911	0.00305	CcSEcCtD
Dolasetron—Chest pain—Acamprosate—alcohol dependence	0.000909	0.00305	CcSEcCtD
Dolasetron—Myalgia—Acamprosate—alcohol dependence	0.000909	0.00305	CcSEcCtD
Dolasetron—Arthralgia—Acamprosate—alcohol dependence	0.000909	0.00305	CcSEcCtD
Dolasetron—Syncope—Naltrexone—alcohol dependence	0.000906	0.00304	CcSEcCtD
Dolasetron—Anxiety—Acamprosate—alcohol dependence	0.000906	0.00304	CcSEcCtD
Dolasetron—Bronchospasm—Citalopram—alcohol dependence	0.000904	0.00303	CcSEcCtD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000903	0.00764	CbGpPWpGaD
Dolasetron—Pancreatitis—Citalopram—alcohol dependence	0.000901	0.00302	CcSEcCtD
Dolasetron—Discomfort—Acamprosate—alcohol dependence	0.000899	0.00301	CcSEcCtD
Dolasetron—Sweating increased—Citalopram—alcohol dependence	0.000895	0.003	CcSEcCtD
Dolasetron—Palpitations—Naltrexone—alcohol dependence	0.000893	0.00299	CcSEcCtD
Dolasetron—Dry mouth—Acamprosate—alcohol dependence	0.000889	0.00298	CcSEcCtD
Dolasetron—Loss of consciousness—Naltrexone—alcohol dependence	0.000888	0.00298	CcSEcCtD
Dolasetron—Cough—Naltrexone—alcohol dependence	0.000882	0.00296	CcSEcCtD
Dolasetron—Confusional state—Acamprosate—alcohol dependence	0.000879	0.00295	CcSEcCtD
Dolasetron—Convulsion—Naltrexone—alcohol dependence	0.000876	0.00293	CcSEcCtD
Dolasetron—Hypertension—Naltrexone—alcohol dependence	0.000873	0.00292	CcSEcCtD
Dolasetron—Anaphylactic shock—Acamprosate—alcohol dependence	0.000872	0.00292	CcSEcCtD
Dolasetron—Arthralgia—Naltrexone—alcohol dependence	0.00086	0.00288	CcSEcCtD
Dolasetron—Myalgia—Naltrexone—alcohol dependence	0.00086	0.00288	CcSEcCtD
Dolasetron—Chest pain—Naltrexone—alcohol dependence	0.00086	0.00288	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00086	0.00727	CbGpPWpGaD
Dolasetron—Dysuria—Citalopram—alcohol dependence	0.000859	0.00288	CcSEcCtD
Dolasetron—Shock—Acamprosate—alcohol dependence	0.000858	0.00287	CcSEcCtD
Dolasetron—Anxiety—Naltrexone—alcohol dependence	0.000857	0.00287	CcSEcCtD
Dolasetron—Thrombocytopenia—Acamprosate—alcohol dependence	0.000854	0.00286	CcSEcCtD
Dolasetron—Tachycardia—Acamprosate—alcohol dependence	0.000851	0.00285	CcSEcCtD
Dolasetron—Discomfort—Naltrexone—alcohol dependence	0.00085	0.00285	CcSEcCtD
Dolasetron—Hyperhidrosis—Acamprosate—alcohol dependence	0.000843	0.00282	CcSEcCtD
Dolasetron—Dry mouth—Naltrexone—alcohol dependence	0.000842	0.00282	CcSEcCtD
Dolasetron—Confusional state—Naltrexone—alcohol dependence	0.000832	0.00279	CcSEcCtD
Dolasetron—Anorexia—Acamprosate—alcohol dependence	0.000831	0.00278	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000825	0.00698	CbGpPWpGaD
Dolasetron—Oedema—Naltrexone—alcohol dependence	0.000825	0.00276	CcSEcCtD
Dolasetron—Anaphylactic shock—Naltrexone—alcohol dependence	0.000825	0.00276	CcSEcCtD
Dolasetron—Pneumonia—Citalopram—alcohol dependence	0.000824	0.00276	CcSEcCtD
Dolasetron—Hypotension—Acamprosate—alcohol dependence	0.000815	0.00273	CcSEcCtD
Dolasetron—Shock—Naltrexone—alcohol dependence	0.000812	0.00272	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000809	0.00684	CbGpPWpGaD
Dolasetron—Acute coronary syndrome—Citalopram—alcohol dependence	0.000808	0.00271	CcSEcCtD
Dolasetron—Tachycardia—Naltrexone—alcohol dependence	0.000805	0.0027	CcSEcCtD
Dolasetron—Myocardial infarction—Citalopram—alcohol dependence	0.000803	0.00269	CcSEcCtD
Dolasetron—HTR3A—nervous system—alcohol dependence	0.0008	0.0423	CbGeAlD
Dolasetron—Stomatitis—Citalopram—alcohol dependence	0.000799	0.00268	CcSEcCtD
Dolasetron—Jaundice—Citalopram—alcohol dependence	0.000799	0.00268	CcSEcCtD
Dolasetron—Hyperhidrosis—Naltrexone—alcohol dependence	0.000797	0.00267	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000794	0.00266	CcSEcCtD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000788	0.00666	CbGpPWpGaD
Dolasetron—Anorexia—Naltrexone—alcohol dependence	0.000786	0.00263	CcSEcCtD
Dolasetron—Paraesthesia—Acamprosate—alcohol dependence	0.000783	0.00262	CcSEcCtD
Dolasetron—Haematuria—Citalopram—alcohol dependence	0.000781	0.00262	CcSEcCtD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000781	0.00661	CbGpPWpGaD
Dolasetron—Dyspnoea—Acamprosate—alcohol dependence	0.000777	0.0026	CcSEcCtD
Dolasetron—Somnolence—Acamprosate—alcohol dependence	0.000775	0.0026	CcSEcCtD
Dolasetron—Epistaxis—Citalopram—alcohol dependence	0.000773	0.00259	CcSEcCtD
Dolasetron—HTR3A—central nervous system—alcohol dependence	0.00077	0.0407	CbGeAlD
Dolasetron—Dyspepsia—Acamprosate—alcohol dependence	0.000767	0.00257	CcSEcCtD
Dolasetron—Decreased appetite—Acamprosate—alcohol dependence	0.000758	0.00254	CcSEcCtD
Dolasetron—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000756	0.00639	CbGpPWpGaD
Dolasetron—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000752	0.00252	CcSEcCtD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000749	0.00634	CbGpPWpGaD
Dolasetron—Bradycardia—Citalopram—alcohol dependence	0.000749	0.00251	CcSEcCtD
Dolasetron—Pain—Acamprosate—alcohol dependence	0.000746	0.0025	CcSEcCtD
Dolasetron—Constipation—Acamprosate—alcohol dependence	0.000746	0.0025	CcSEcCtD
Dolasetron—Paraesthesia—Naltrexone—alcohol dependence	0.000741	0.00248	CcSEcCtD
Dolasetron—Dyspnoea—Naltrexone—alcohol dependence	0.000735	0.00246	CcSEcCtD
Dolasetron—Somnolence—Naltrexone—alcohol dependence	0.000733	0.00246	CcSEcCtD
Dolasetron—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000727	0.00615	CbGpPWpGaD
Dolasetron—Oedema peripheral—Citalopram—alcohol dependence	0.000725	0.00243	CcSEcCtD
Dolasetron—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000723	0.00611	CbGpPWpGaD
Dolasetron—Feeling abnormal—Acamprosate—alcohol dependence	0.000718	0.00241	CcSEcCtD
Dolasetron—Decreased appetite—Naltrexone—alcohol dependence	0.000717	0.0024	CcSEcCtD
Dolasetron—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000713	0.00239	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000712	0.00603	CbGpPWpGaD
Dolasetron—Fatigue—Naltrexone—alcohol dependence	0.000711	0.00238	CcSEcCtD
Dolasetron—Visual impairment—Citalopram—alcohol dependence	0.000709	0.00238	CcSEcCtD
Dolasetron—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000706	0.00598	CbGpPWpGaD
Dolasetron—Pain—Naltrexone—alcohol dependence	0.000705	0.00236	CcSEcCtD
Dolasetron—Constipation—Naltrexone—alcohol dependence	0.000705	0.00236	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000698	0.00591	CbGpPWpGaD
Dolasetron—Urticaria—Acamprosate—alcohol dependence	0.000693	0.00232	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000692	0.00586	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000691	0.00584	CbGpPWpGaD
Dolasetron—Abdominal pain—Acamprosate—alcohol dependence	0.000689	0.00231	CcSEcCtD
Dolasetron—Body temperature increased—Acamprosate—alcohol dependence	0.000689	0.00231	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000686	0.0058	CbGpPWpGaD
Dolasetron—Tinnitus—Citalopram—alcohol dependence	0.000686	0.0023	CcSEcCtD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000685	0.00579	CbGpPWpGaD
Dolasetron—Flushing—Citalopram—alcohol dependence	0.000683	0.00229	CcSEcCtD
Dolasetron—Feeling abnormal—Naltrexone—alcohol dependence	0.00068	0.00228	CcSEcCtD
Dolasetron—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000674	0.00226	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000673	0.00569	CbGpPWpGaD
Dolasetron—Chills—Citalopram—alcohol dependence	0.00066	0.00221	CcSEcCtD
Dolasetron—Arrhythmia—Citalopram—alcohol dependence	0.000657	0.0022	CcSEcCtD
Dolasetron—Urticaria—Naltrexone—alcohol dependence	0.000655	0.0022	CcSEcCtD
Dolasetron—Abdominal pain—Naltrexone—alcohol dependence	0.000652	0.00219	CcSEcCtD
Dolasetron—Body temperature increased—Naltrexone—alcohol dependence	0.000652	0.00219	CcSEcCtD
Dolasetron—Hypersensitivity—Acamprosate—alcohol dependence	0.000642	0.00215	CcSEcCtD
Dolasetron—Flatulence—Citalopram—alcohol dependence	0.000631	0.00211	CcSEcCtD
Dolasetron—Dysgeusia—Citalopram—alcohol dependence	0.000627	0.0021	CcSEcCtD
Dolasetron—Asthenia—Acamprosate—alcohol dependence	0.000626	0.0021	CcSEcCtD
Dolasetron—Pruritus—Acamprosate—alcohol dependence	0.000617	0.00207	CcSEcCtD
Dolasetron—HTR3A—brain—alcohol dependence	0.000611	0.0323	CbGeAlD
Dolasetron—CYP2C9—cardiovascular system—alcohol dependence	0.00061	0.0323	CbGeAlD
Dolasetron—Hypersensitivity—Naltrexone—alcohol dependence	0.000608	0.00204	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000606	0.00512	CbGpPWpGaD
Dolasetron—Tremor—Citalopram—alcohol dependence	0.0006	0.00201	CcSEcCtD
Dolasetron—Diarrhoea—Acamprosate—alcohol dependence	0.000597	0.002	CcSEcCtD
Dolasetron—Ill-defined disorder—Citalopram—alcohol dependence	0.000594	0.00199	CcSEcCtD
Dolasetron—Anaemia—Citalopram—alcohol dependence	0.000592	0.00198	CcSEcCtD
Dolasetron—Asthenia—Naltrexone—alcohol dependence	0.000592	0.00198	CcSEcCtD
Dolasetron—Agitation—Citalopram—alcohol dependence	0.000588	0.00197	CcSEcCtD
Dolasetron—Angioedema—Citalopram—alcohol dependence	0.000585	0.00196	CcSEcCtD
Dolasetron—Pruritus—Naltrexone—alcohol dependence	0.000584	0.00196	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000583	0.00494	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000579	0.0049	CbGpPWpGaD
Dolasetron—Malaise—Citalopram—alcohol dependence	0.000577	0.00194	CcSEcCtD
Dolasetron—Dizziness—Acamprosate—alcohol dependence	0.000577	0.00193	CcSEcCtD
Dolasetron—Vertigo—Citalopram—alcohol dependence	0.000575	0.00193	CcSEcCtD
Dolasetron—Syncope—Citalopram—alcohol dependence	0.000574	0.00192	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000574	0.00485	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000572	0.00484	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000571	0.00483	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000567	0.0048	CbGpPWpGaD
Dolasetron—Palpitations—Citalopram—alcohol dependence	0.000566	0.0019	CcSEcCtD
Dolasetron—Diarrhoea—Naltrexone—alcohol dependence	0.000564	0.00189	CcSEcCtD
Dolasetron—Loss of consciousness—Citalopram—alcohol dependence	0.000563	0.00189	CcSEcCtD
Dolasetron—CYP2D6—brainstem—alcohol dependence	0.000561	0.0297	CbGeAlD
Dolasetron—Cough—Citalopram—alcohol dependence	0.000559	0.00187	CcSEcCtD
Dolasetron—Convulsion—Citalopram—alcohol dependence	0.000555	0.00186	CcSEcCtD
Dolasetron—Hypertension—Citalopram—alcohol dependence	0.000553	0.00185	CcSEcCtD
Dolasetron—Rash—Acamprosate—alcohol dependence	0.00055	0.00184	CcSEcCtD
Dolasetron—Dermatitis—Acamprosate—alcohol dependence	0.000549	0.00184	CcSEcCtD
Dolasetron—Headache—Acamprosate—alcohol dependence	0.000546	0.00183	CcSEcCtD
Dolasetron—Dizziness—Naltrexone—alcohol dependence	0.000545	0.00183	CcSEcCtD
Dolasetron—Arthralgia—Citalopram—alcohol dependence	0.000545	0.00183	CcSEcCtD
Dolasetron—Myalgia—Citalopram—alcohol dependence	0.000545	0.00183	CcSEcCtD
Dolasetron—Chest pain—Citalopram—alcohol dependence	0.000545	0.00183	CcSEcCtD
Dolasetron—Anxiety—Citalopram—alcohol dependence	0.000543	0.00182	CcSEcCtD
Dolasetron—CYP2D6—forebrain—alcohol dependence	0.000542	0.0286	CbGeAlD
Dolasetron—Discomfort—Citalopram—alcohol dependence	0.000539	0.00181	CcSEcCtD
Dolasetron—Dry mouth—Citalopram—alcohol dependence	0.000533	0.00179	CcSEcCtD
Dolasetron—Confusional state—Citalopram—alcohol dependence	0.000527	0.00177	CcSEcCtD
Dolasetron—Oedema—Citalopram—alcohol dependence	0.000523	0.00175	CcSEcCtD
Dolasetron—Anaphylactic shock—Citalopram—alcohol dependence	0.000523	0.00175	CcSEcCtD
Dolasetron—Rash—Naltrexone—alcohol dependence	0.00052	0.00174	CcSEcCtD
Dolasetron—Dermatitis—Naltrexone—alcohol dependence	0.00052	0.00174	CcSEcCtD
Dolasetron—Headache—Naltrexone—alcohol dependence	0.000517	0.00173	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000515	0.00436	CbGpPWpGaD
Dolasetron—Shock—Citalopram—alcohol dependence	0.000514	0.00172	CcSEcCtD
Dolasetron—Thrombocytopenia—Citalopram—alcohol dependence	0.000512	0.00171	CcSEcCtD
Dolasetron—Tachycardia—Citalopram—alcohol dependence	0.00051	0.00171	CcSEcCtD
Dolasetron—CYP2C9—digestive system—alcohol dependence	0.000507	0.0268	CbGeAlD
Dolasetron—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000505	0.00428	CbGpPWpGaD
Dolasetron—Hyperhidrosis—Citalopram—alcohol dependence	0.000505	0.00169	CcSEcCtD
Dolasetron—Anorexia—Citalopram—alcohol dependence	0.000498	0.00167	CcSEcCtD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000494	0.00418	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000492	0.00416	CbGpPWpGaD
Dolasetron—Hypotension—Citalopram—alcohol dependence	0.000488	0.00164	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000488	0.00413	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000487	0.00412	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000485	0.00411	CbGpPWpGaD
Dolasetron—CYP2C9—blood—alcohol dependence	0.000483	0.0255	CbGeAlD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000482	0.00408	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00048	0.00406	CbGpPWpGaD
Dolasetron—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000476	0.0016	CcSEcCtD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000476	0.00402	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000474	0.00401	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000469	0.00397	CbGpPWpGaD
Dolasetron—Paraesthesia—Citalopram—alcohol dependence	0.000469	0.00157	CcSEcCtD
Dolasetron—Dyspnoea—Citalopram—alcohol dependence	0.000466	0.00156	CcSEcCtD
Dolasetron—Somnolence—Citalopram—alcohol dependence	0.000465	0.00156	CcSEcCtD
Dolasetron—Dyspepsia—Citalopram—alcohol dependence	0.00046	0.00154	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000457	0.00386	CbGpPWpGaD
Dolasetron—Decreased appetite—Citalopram—alcohol dependence	0.000454	0.00152	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000452	0.00382	CbGpPWpGaD
Dolasetron—Fatigue—Citalopram—alcohol dependence	0.000451	0.00151	CcSEcCtD
Dolasetron—Pain—Citalopram—alcohol dependence	0.000447	0.0015	CcSEcCtD
Dolasetron—Constipation—Citalopram—alcohol dependence	0.000447	0.0015	CcSEcCtD
Dolasetron—Feeling abnormal—Citalopram—alcohol dependence	0.000431	0.00144	CcSEcCtD
Dolasetron—Gastrointestinal pain—Citalopram—alcohol dependence	0.000427	0.00143	CcSEcCtD
Dolasetron—CYP2C9—endocrine gland—alcohol dependence	0.000419	0.0221	CbGeAlD
Dolasetron—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000418	0.00354	CbGpPWpGaD
Dolasetron—Urticaria—Citalopram—alcohol dependence	0.000415	0.00139	CcSEcCtD
Dolasetron—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000415	0.00351	CbGpPWpGaD
Dolasetron—Body temperature increased—Citalopram—alcohol dependence	0.000413	0.00138	CcSEcCtD
Dolasetron—Abdominal pain—Citalopram—alcohol dependence	0.000413	0.00138	CcSEcCtD
Dolasetron—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000401	0.00339	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000398	0.00336	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000389	0.00329	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000388	0.00328	CbGpPWpGaD
Dolasetron—CYP3A4—digestive system—alcohol dependence	0.000386	0.0204	CbGeAlD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000386	0.00326	CbGpPWpGaD
Dolasetron—Hypersensitivity—Citalopram—alcohol dependence	0.000385	0.00129	CcSEcCtD
Dolasetron—CYP2D6—digestive system—alcohol dependence	0.00038	0.0201	CbGeAlD
Dolasetron—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000378	0.0032	CbGpPWpGaD
Dolasetron—CYP2C9—liver—alcohol dependence	0.000377	0.0199	CbGeAlD
Dolasetron—Asthenia—Citalopram—alcohol dependence	0.000375	0.00126	CcSEcCtD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000374	0.00317	CbGpPWpGaD
Dolasetron—Pruritus—Citalopram—alcohol dependence	0.00037	0.00124	CcSEcCtD
Dolasetron—CYP3A4—blood—alcohol dependence	0.000368	0.0194	CbGeAlD
Dolasetron—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000367	0.0031	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000364	0.00308	CbGpPWpGaD
Dolasetron—CYP2D6—blood—alcohol dependence	0.000362	0.0191	CbGeAlD
Dolasetron—Diarrhoea—Citalopram—alcohol dependence	0.000358	0.0012	CcSEcCtD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000356	0.00302	CbGpPWpGaD
Dolasetron—Dizziness—Citalopram—alcohol dependence	0.000346	0.00116	CcSEcCtD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00033	0.00279	CbGpPWpGaD
Dolasetron—Rash—Citalopram—alcohol dependence	0.00033	0.0011	CcSEcCtD
Dolasetron—Dermatitis—Citalopram—alcohol dependence	0.000329	0.0011	CcSEcCtD
Dolasetron—Headache—Citalopram—alcohol dependence	0.000327	0.0011	CcSEcCtD
Dolasetron—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000322	0.00272	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00032	0.00271	CbGpPWpGaD
Dolasetron—CYP3A4—endocrine gland—alcohol dependence	0.000319	0.0169	CbGeAlD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000318	0.00269	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000317	0.00268	CbGpPWpGaD
Dolasetron—CYP2D6—endocrine gland—alcohol dependence	0.000314	0.0166	CbGeAlD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000314	0.00265	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00031	0.00262	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000304	0.00257	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000301	0.00255	CbGpPWpGaD
Dolasetron—CYP2D6—testis—alcohol dependence	0.0003	0.0158	CbGeAlD
Dolasetron—CYP3A4—nervous system—alcohol dependence	0.000299	0.0158	CbGeAlD
Dolasetron—CYP2D6—nervous system—alcohol dependence	0.000294	0.0155	CbGeAlD
Dolasetron—CYP3A4—liver—alcohol dependence	0.000288	0.0152	CbGeAlD
Dolasetron—CYP3A4—central nervous system—alcohol dependence	0.000288	0.0152	CbGeAlD
Dolasetron—CYP2D6—liver—alcohol dependence	0.000283	0.015	CbGeAlD
Dolasetron—CYP2D6—central nervous system—alcohol dependence	0.000283	0.015	CbGeAlD
Dolasetron—CYP2D6—cerebellum—alcohol dependence	0.000277	0.0146	CbGeAlD
Dolasetron—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000274	0.00231	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000273	0.00231	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000262	0.00222	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000258	0.00219	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000257	0.00217	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000256	0.00217	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000255	0.00216	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000254	0.00215	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.00024	0.00203	CbGpPWpGaD
Dolasetron—CYP2D6—brain—alcohol dependence	0.000225	0.0119	CbGeAlD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000209	0.00177	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000208	0.00176	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000207	0.00175	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000207	0.00175	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000205	0.00173	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000204	0.00172	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000202	0.00171	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000199	0.00168	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.00019	0.00161	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000188	0.00159	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.00017	0.00144	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000169	0.00143	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000169	0.00143	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000168	0.00142	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000136	0.00115	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000135	0.00114	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000133	0.00113	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000124	0.00105	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADH6—alcohol dependence	0.000119	0.00101	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000118	0.001	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000111	0.00094	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—POMC—alcohol dependence	0.000111	0.000937	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.00011	0.000928	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADH1A—alcohol dependence	9.9e-05	0.000837	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADH1A—alcohol dependence	9.81e-05	0.00083	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADH4—alcohol dependence	8.41e-05	0.000712	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADH4—alcohol dependence	8.34e-05	0.000706	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADH6—alcohol dependence	7.81e-05	0.000661	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.24e-05	0.000612	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.22e-05	0.000611	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADH7—alcohol dependence	7.15e-05	0.000605	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADH7—alcohol dependence	7.09e-05	0.0006	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GGT2—alcohol dependence	6.86e-05	0.00058	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GGT2—alcohol dependence	6.8e-05	0.000575	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.47e-05	0.000547	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADH1B—alcohol dependence	6.27e-05	0.000531	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADH1B—alcohol dependence	6.22e-05	0.000526	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADH4—alcohol dependence	5.5e-05	0.000465	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MAOB—alcohol dependence	5.2e-05	0.00044	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MAOB—alcohol dependence	5.15e-05	0.000436	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADH7—alcohol dependence	4.68e-05	0.000396	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GGT2—alcohol dependence	4.48e-05	0.000379	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDH2—alcohol dependence	4.42e-05	0.000374	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.38e-05	0.000371	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.21e-05	0.000357	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.1e-05	0.000347	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GOT2—alcohol dependence	3.76e-05	0.000318	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GOT2—alcohol dependence	3.73e-05	0.000315	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.53e-05	0.000299	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.5e-05	0.000296	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MAOB—alcohol dependence	3.4e-05	0.000288	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GOT1—alcohol dependence	3.24e-05	0.000275	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GGT1—alcohol dependence	3.24e-05	0.000275	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GGT1—alcohol dependence	3.22e-05	0.000272	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GOT1—alcohol dependence	3.22e-05	0.000272	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MAOA—alcohol dependence	2.91e-05	0.000246	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.89e-05	0.000245	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MAOA—alcohol dependence	2.88e-05	0.000244	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.8e-05	0.000237	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GOT2—alcohol dependence	2.46e-05	0.000208	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.31e-05	0.000195	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GOT1—alcohol dependence	2.12e-05	0.000179	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GGT1—alcohol dependence	2.12e-05	0.000179	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MAOA—alcohol dependence	1.9e-05	0.000161	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—POMC—alcohol dependence	1.89e-05	0.00016	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—POMC—alcohol dependence	1.88e-05	0.000159	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—EP300—alcohol dependence	1.26e-05	0.000106	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—EP300—alcohol dependence	1.24e-05	0.000105	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—POMC—alcohol dependence	1.24e-05	0.000105	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—EP300—alcohol dependence	8.21e-06	6.95e-05	CbGpPWpGaD
